Epidemiology of MS in Russia, a historical review by A. Boyko et al.
Multiple Sclerosis and
Demyelinating Disorders
Boyko et al. Multiple Sclerosis and Demyelinating Disorders  (2016) 1:13 
DOI 10.1186/s40893-016-0016-9REVIEW Open AccessEpidemiology of MS in Russia, a historical
review
A. Boyko*, N. Smirnova, S. Petrov and E. GusevAbstract
Background: This review summarizes several epidemiological studies of multiple sclerosis (MS) in Russia.
Methods: The Authors selected the most well-organized population-based studies of MS prevalence and
incidence in the huge territory of Russia. These studies were mostly published in Russian language and were
unknown to international readers.
Results: In the majority of Russian territories MS prevalence ranged from 30 to 70 cases per 100,000 population
inhabitants. At most places where the epidemiology of MS had been assessed more than once, an increase in
prevalence has been reported over time. Incidence showed fluctuations with an increase in Eastern parts of the
country. This increased prevalence despite a relatively stable incidence in the European part of the country may
reflect the increased survival of the MS population.
Conclusions: Russia as a whole can be considered at medium risk for MS. Significant increase of prevalence rates
have been recently reported, especially in Siberia and in the Far East regions of the country.
Keywords: Multiple sclerosis, Epidemiology, Prevalence rates, RussiaBackground
One of the most striking epidemiological characteristics of
MS is the distribution of the disease across the world. The
traditional view, based on numerous early studies and re-
views, is that MS is particularly prevalent in low temperate
zones, less common in subtropical zones, and uncommon
in tropic zones. Both in the Northern and Southern hemi-
sphere the characteristic pattern have been increasing
prevalence towards the poles, although deviations from this
pattern can be seen both in Europe and North America as
well as in Australia and New Zealand. This distribution
suggests an interplay between at least three overlapping
factors, a) the genetic makeup of a population; b) geograph-
ically determined environmental factors; and c) socio-
economic conditions, including access to medical facilities.
Data from the former USSR and late from Russia have
never been reported so far in the English literature. In
1960-1970’s, the prevalence of MS on the huge territory of
the former Soviet Union was reported as at “probably high
risk of MS”. Ten years later, the famous world distribution* Correspondence: boykoan13@gmail.com
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the majority of regions of the Soviet Union [20]. A first
review was performed in 1994 and was mainly based on
hospital registers. Although a number of factors may have
affected the validity of these first observations, including
inconsistencies of diagnostic facilities among different terri-
tories [2, 3], bad cases ascertainment, differences in ethnic
features, high migration rate and different epidemiological
methods. In any case, overall MS prevalence was reported
in the low to medium frequency range [23, 26].
Since then, the availability of medical service has had a
profound impact on the diagnostic accuracy and prob-
ability ascertainment, and these factors have improved
in most parts of the world and have been more uniform
throughout the last three to four decades. After the
1990s, the quality of medical care and the availability of
diagnostic methods, including MRI, has become uniform
in all Russian territories. A special national program on
MS epidemiology was launched in 2002 and new studies,
performed according to generally accepted methodolo-
gies, provided new information which could be com-
pared with previous studies [5, 6]. The structure and
design of these studies were established by a specialle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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[11]. Recently the majority of these studies were
reviewed [12]. The goal of this publication is to present
data on MS prevalence and incidence in Russia, which
were published previously only in Russian language.
Materials and methods
Russia is the largest country in the World. Its territory
is 17.1 million of km2 and it accounts approximately
for 1/8 of the land mass of the Earth. One third of this
country in located in Europe, while 2/3 belongs to
Asia. Climate in Russia is quite heterogeneous. For
example, in Sochi – Olympic capital of 2014 – average
winter temperature is +5 °C, i.e. a temperate zone;
Novosibirsk, the biggest city of Siberia with a popula-
tion of 1.5 million, shows an average winter
temperature of – 15 °C; at the same time in Oimyakon
area of Yakutia, known as the “cold pole”, the average
winter temperature is – 61 °C: obviously, people
cannot live or work in such low temperature. Approxi-
mately 20 % of the Russian population resides in the
13 biggest cities: Moscow, St Petersburg, Novosibirsk,
Nizhniy Novgorod, Yekaterinburg, Samara, Omsk,
Kazan, Chelyabinsk, Rostov-on-Don, Ufa, Volgograd,
Perm. The largest cities of Russia are located in the
European part of the country – Moscow (11.54 mil-
lion) and Saint-Petersburg (4.8 million), while more
than 10 million are living in the republics of the
Northern Caucasus. With 145 million people Russia is
the seventh most populated nation in the world. While
some 79 % of the residents are Russians, more than
160 ethnic groups live in this huge territory (each of
them carrying its own genetic predisposition to MS),
including Tatars (20 %), Ukrainians (10 %), Bashkirs
(6 %), Chuvash (6 %), Chechen (5 %), Armenians (4 %),
and Mordva (3 %). In Russia there are 1147 women per
1000 men [7]. This overrepresentation of women
becomes more evident from 33 years of age on. Russia
is young country, with a mean population age of
38.8 years in 2010, 36.1 in men and 41.1 in women.
The oldest inhabitants are in the Central European
area (in the city of Tula mean 42.2 years old, 38.5 for
men and 45.2 for women), the youngest in Northern
Caucases (in the Ingushetia republic, mean age is
29.6 years old; 28.8 for men and 30.4 for women).
Able-bodied population (men 16-59 age and women
16-54 age) is 89,0 million (61 %), while the remaining
is either younger – 26,3 million (18 %) – or elder –
29,8 million (21 %). For Russia, as for most European
countries, progressive ageing of inhabitants is increasingly
common. According to the national census of 1989, mean
age of the population is 34,7 years; 31,9 for man, 37,2 for
woman [7]. Since then, mean age of residents has
increased by 3 years and reached 37,7 years; 35,2 for man,40,0 for woman. Literacy in Russia is 99 %. There are
about 3 million students and 567 institutes of higher
education including 48 universities.
The National program on MS epidemiology in Russia
was started in 2002. The first step was to establish a
network of MS Centers covering the entire country,
using as a model the successful Moscow MS Center
(established in 1998). The program mostly contemplates
two actions: descriptive epidemiology – i.e. analysis of
prevalence and incidence using unified methodology of
population-based studies and analytical epidemiology –
case-control studies in different populations analyzing
environmental risk factors for MS, case-control pairs
matched by age, gender, ethnicity and place of birth. All
studies are conducted using a unique methodology that
includes the validated questionnaire proposed by the
Oslo International Think-tank on MS Epidemiology
published in Neurology in 1997 [4].
At present more than 90 studies analyzing MS preva-
lence and incidence in periods between 1980 and 2013
have been published within this program: they may be
compared with some of the best quality studies, done in
the 1970-1980 decade. Is several regions (Moscow,
Novosibirsk, Blagoveshensk) longitudinal observations
for 30 and more years have been done. For this review
we have selected data from 68 population-based studies
of the best quality from different regions of Russia.
These studies used unified design of data collection,
evaluation of MS clinical course and methods of statis-
tical analysis.
Results
The majority of studies used clinical Poser diagnostic
criteria while more recent studies, performed after 2005
(7 from 68 to 10.3 %), used the 2001 McDonald criteria.
Generally, MS prevalence varied from 10 to 70 cases per
100,000 population with higher MS frequencies at the
West, East and Central parts of the country (Fig. 1). A
lower prevalence was recorded in Northern areas and in
the Far East of Russia, where a low population density
and higher representation of populations of Asian origin
including Northern tribes, still less affected by MS,
occurs.
Data from some of the studies done in different time
periods are presented in the Table and show that there is
a general tendency of increasing of MS prevalence
almost everywhere in Russia. Explanations for this
worldwide occurring phenomenon include: 1) better
cases ascertainment because of early diagnosis with a
percentage increase of mild cases; 2) free access to
DMT, active symptomatic and antibacterial therapy
extending the life of MS patients; and 3) no loss of infor-
mation about these patients because of the general use




Fig. 1 MS prevalence in different regions of Russia (studied at three time periods: 1980-1990, 1990-2000 and 2000-2010)
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reduced the percent of severely affected MS patients.
The most striking increase of MS prevalence and inci-
dence was noted in Eastern Siberia and in the Far East,
where MS frequency increased among third generation of
migrants from the European part of Russia. The risk of
MS appears to be very homogeneous and varies from 20
to 60 cases per 100,000 population [6] with the majority
of populations predominantly Russian, Ukrainian or from
other European Caucasoid origin (e.g. Slavonics). Table 1
includes prevalence data from the East to the West of the
Russian Federation; Table 2 includes incidence data.
Eastern and Central part of Russia
The most recent rates of MS prevalence vary from 35
cases per 100,000 in Kostroma up to 67 in Voronezh.
Recent MS incidence rates were 2.8 in Yaroslavl and 2.6 in
Moscow region, 2.1 in Voronezh, 2.0 in Kostroma and 1.9
in Orel and Nizhniy Novgorod cities [13, 15, 18]. An
increase in MS incidence in the Yaroslavl region was seen
from 1975 (0.5 per 100,000 population) up to mean 3.0
between 1996 and 2001 (highest rate: 3.1 in 1998) but
then decreased to 2.5 between 2001 and 2006 [15]. In the
Moscow region, MS incidence was 2.1 between 1995 and
2000 and rose to 2.6 between 2001 and 2006 [6].
Volga river region
The ethnicity of the population of this area is very differ-
ent from the Moscow region, with many non-Slavicethnic groups (Turks) – Tatars, Bashkirs, Chuvashes, as
well as the Finno-Ugric group – Mari and Udmurts. MS
epidemiological studies in this area showed lower inci-
dence and prevalence rates compared to the Central
region of the country with some variation. For example,
in Bashkiria the lowest MS prevalence rate reported was
21 per 100,000 population but up to 79 per 100,000 in
Northern parts of the republic (the highest in recent
studies). Surprisingly, MS prevalence in Ufa, the capital
of this republic, was the highest among the Tatars (36.4
per 100,000), intermediate in Russians (near 23 per
100,000), and lowest in Bashkirs (9 per 100,000) [1]. By
comparison, at the Moscow region MS is significantly
less frequent in Tatars then in Russians. Mean MS
incidence in these republics were 2.6 per 100,000, the
highest in the city of Kazan (2.9 per 100,000) [14, 19].Southern parts of Russia and the Northern Caucasus
In these areas rates are again lower than in the Central
part of Russia, varying from 20 to 35 per 100,000 [30],
while in some cities the mean MS incidence was very
high: in the past few years it increased up to 9.8 in 2000-
2005 period in the city of Volgograd [8]. In the neigh-
boring Rostov, region the prevalence of MS also varies
from district to district with the lowest – 19.5 per
100,000 – in the rural eastern part, and the highest –
53.6 per 100,000 – in the northwestern part with indus-
trial enterprises and cities [10]. MS is relatively rare in
Table 1 MS prevalence in Russia at different time periods
Cities/regions 1980-1989 1990-1999 2000-2010









Nizhniy Novgorod 38 39
Ryazan 61
Volga-river regions (near 30 mlns of population, 40 % Slavonik,
50 % Turks, 10 % others)
Republic of Tatarstan 32 33
Kazan (capital of Tatarstan) 38 46
Republic of Bashkiria 35 50 56
Northern parts of Bashkiria 79
Ufa (capital of Bashkiria) 31 59
Republic of Chuvashia 14 19
Southern parts of Russia and the Northern Caucuses (near 30 mlns of





Republic of Karachaero-Cherkessia 17 20
Republic of Dagestan 10 19
Republic of Adigea 13 18
Republic of Northern Osetia 16 20
Republic of Chechnya 5 9
Ural region and the Western Siberia (near 10 mlns of population,
70 % Slavonik, 30 % others)
Tyumen 19 34







The Eastern Siberia and the Far East (near 5 mlns of population,
80 % Slavonik, 20 % others)




Table 1 MS prevalence in Russia at different time periods
(Continued)
Altay region 40
The Primorsk region 10 17
Vladivostok 11 16
The Northern part of Sakhalin 19
The Southern part of Sakhalin 17
The Northern part of Kamchatka 12 17
The Southern part of Kamchatka 15 23
Magadan 11
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lence less than 20 at majority of sites (Table 1).
Ural region and the Western Siberia
Several population-based studies were recently completed
in the Tyumen region and in the city of Novosibirsk. The
Tyumen region is divided in three parts: the Northern
Yamal region, scarcely populated, where 6.8 % of the popu-
lation descends from the Northern tribes (Nentsi, Mansy,
Khanti and others) and shows a medium level MS preva-
lence – 27.8 per 100,000 [27, 28]. Conversely, the Khanti-
Mansi region, consistently more populated and with onlyTable 2 Some recent MS incidence rates in Russia (according to
latest published data)
Cities MS incidence
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has an MS prevalence of only 14.3 per 100,000. The
highest prevalence, close to 40.5 per 100,000, was found in
the Southern part of the region with mostly populated by
Russians and hosting many chemical factories. A very
important result of this study was the first recorded cases
of definite MS in the Northern tribes – overall the preva-
lence in this area was 2.8 per 100,000 population (highest
in Komi-Ziriane ethnic group – up to 16 per 100,000) [29].
A retrospective study covering 25 years in Novosibirsk
demonstrated a significant increase in MS incidence in
this territory between 1980 and 2000 that rose from 1.6
up to 5.4 cases per 100,000 [21]. Current incidence in
this area has stabilized between 2.5 and 3.5 cases per
100,000 population. MS prevalence here in one the
highest in the entire Siberia region – near 60 cases per
100,000 population [22].
The Eastern Siberia and the Far East
A population-based study was performed in Yakutia. Previ-
ous studies in this area were completed in the 1980’s,
apparently based mainly on hospital cases. MS prevalence
(2.1 per 100,000) and incidence (0,2 per 100,000) were
reported to be extremely low. The first MRI scanner in this
region started to work in 1993. The first clinically definite
MS case according to Poser criteria in native Yakuts was
reported only in 1995, with the first autopsy confirmed MS
case obtained in 1998. In the following years native Yakuts
withnessed a surge of the disease in their community.
More than half young cases were women with numerous
lesions at spinal cord at early stages of the disease (“Asian”
type of MS). Between 2000 and 2005 the rates in Russians
were higher than in Yakuts, but in this ethnic group the
prevalence rate was 13.4 per 100,000 in the city and 4.2 per
100,000 in rural regions, while the incidence was 1.8 and
0.4, respectively. Mean MS prevalence in 2002-2007 was
19 cases per 100,000 [24]. MS incidence at the Amur
region varied from 2.8 in 1980-1985 to 0.3 in 2000-2005
[16, 17]. Overall, MS prevalence (1985-2010) varied in this
area from 30 to 50 cases per 100,000 [25]. Recent studies
of MS prevalence and incidence at the Far East region
show relatively low frequencies with MS prevalence from
11 to 23 cases per 100,000 population [9].
Conclusions
This short review shows that the majority of territories of
Russia fall into the medium MS risk zone with a preva-
lence ranging mostly from 30 to 70 cases per 100,000
population. At most places where the prevalence of MS
has been studied on more than once, a definite increase
has occurred, similarly to the rest of the Western world
[26]. Incidence rates displayed a fluctuating trend, with a
clear-cut increase in Eastern parts of the country. This in-
creased prevalence, despite a relatively stable incidence inthe European part of the country, may be partially due to
an increased survival of the patients as a result of a com-
bination of positive changes. An overall improved medical
care, more complete ascertainment procedures and differ-
ential emigration of unaffected people [MS was more
frequent in Caucasoids Slavoniks then in non-Caucasoid
ethnic groups (Turks, Yarutes, etc.)] were all considered as
possible contributing factors.
Although an influence of environmental factors must
be taken into consideration in determining the sketchy
epidemiology if MS in Russia, our data do not allow
strong conclusions. The influence of temperature could
not be properly assessed because of instability and great
variations at the majority of the regions. The increase
of MS prevalence in the third generation of the
migrants to the Far East suggest a role for ecological
and other unknown urban factors. Improvement in
diagnosis and/or case ascertainment could certainly
lead to a technology-driven increased incidence and
prevalence rates, especially in the1980-1990 period.
Therefore, the data on increase in incidence of MS
across this time period should be interpreted with
caution. The correction for delay in ascertainment may
be inaccurate to some degree. On the other hand, it is
now evident that many territories and ethnic groups
from Russia, thought to be free of MS, actually display
low and medium levels of MS prevalence.
In conclusion, for this review we have selected
population-based, peer-reviewed studies of MS prevalence
and incidence in Russia, performed according to modern
technology. We are not providing age-standardized,
ethnic-specific or sex-specific data, which were not
recorded in the majority of the studies. A further analysis
and classification of the data presented in Russian-
speaking literature along with consistently designed,
perspective epidemiological studies are clearly needed to
clarify the complex scenario of MS in the Russian
confederation.
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